TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
163,358
|
153,555
|
157,865 |
| Financial expenses |
2,983
|
3,819
|
2,324 |
| Earnings before taxes |
5,240
|
4,198
|
6,195 |
| EBITDA |
6,334
|
5,925
|
6,546 |
| Total assets |
91,735
|
101,174
|
132,245 |
| Current assets |
87,356
|
94,924
|
124,311 |
| Current liabilities |
37,890
|
59,600
|
81,858 |
| Equity capital |
36,789
|
32,923
|
29,813 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
21
|
23
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.1%
|
32.5%
|
22.5% |
| Turnover per employee |
7,779
|
6,676
|
8,770 |
| Profit as a percentage of turnover |
3.2%
|
2.7%
|
3.9% |
| Return on assets (ROA) |
9.0%
|
7.9%
|
6.4% |
| Current ratio |
230.6%
|
159.3%
|
151.9% |
| Return on equity (ROE) |
14.2%
|
12.8%
|
20.8% |
| Change turnover |
9,803
|
-4,310
|
-15,504 |
| Change turnover % |
6%
|
-3%
|
-9% |
| Chg. No. of employees |
-2
|
5
|
-13 |
| Chg. No. of employees % |
-9%
|
28%
|
-42% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.